VeriMomБезопасен ли cloflucarban при беременности?
No harmonised CLP reproductive classification or CIR/SCCS safety opinion was identified for cloflucarban; available literature does not report reproductive or teratogenic effects. The substance is listed as a cosmetic antimicrobial/antiperspirant ingredient in EU documents (i.e., used topically), and chemical databases (PubChem/Fisher) describe it as a lipophilic antibacterial carbanilide, so low but measurable dermal exposure from topical cosmetic use is plausible. Sources: Official Journal / CosIng listing, PubChem/Fisher. (See sources.)
Related ingredients
Frequently asked questions
- Безопасен ли cloflucarban при беременности?
- No harmonised CLP reproductive classification or CIR/SCCS safety opinion was identified for cloflucarban; available literature does not report reproductive or teratogenic effects. The substance is listed as a cosmetic antimicrobial/antiperspirant ingredient in EU documents (i.e., used topically), and chemical databases (PubChem/Fisher) describe it as a lipophilic antibacterial carbanilide, so low but measurable dermal exposure from topical cosmetic use is plausible. Sources: Official Journal / CosIng listing, PubChem/Fisher. (See sources.)
- Безопасен ли cloflucarban при грудном вскармливании?
- No data were found showing reproductive or lactation-specific toxicity or transfer to milk; no harmonised hazards (H360/H361) or CIR/SCCS opinions indicating risk. Topical use implies low but measurable exposure; without milk-transfer data this is conservatively treated as low exposure. Sources: searches of regulatory databases and PubMed (no lactation data found).
- Безопасен ли cloflucarban для кожи малыша?
- No infant-specific reproductive/toxicity data were identified. Because cloflucarban is a lipophilic topical antimicrobial used in deodorants/soaps (i.e., it is not non-absorbable), immature infant skin gives higher systemic uptake potential; per scoring rules that justifies increasing exposure score by +1 for 0–3 yr. No evidence was found to increase hazard or mechanism scores for infants. Sources: Official Journal / CosIng listing, PubChem, lack of infant-specific studies on PubMed.
- Как VeriMom оценивает cloflucarban?
- VeriMom оценивает cloflucarban в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы cloflucarban при беременности?
- См. наш список безопасных альтернатив cloflucarban с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.